Menu
Search
|

Menu

Close
X

Laboratory Corporation of America Holdings LH.N (New York Stock Exchange)

183.61 USD
-2.83 (-1.52%)
As of 11:46 AM EDT
chart
Previous Close 186.44
Open 185.47
Volume 43,999
3m Avg Volume 186,393
Today’s High 186.15
Today’s Low 183.28
52 Week High 190.35
52 Week Low 147.19
Shares Outstanding (mil) 102.00
Market Capitalization (mil) 19,095.66
Forward P/E 25.94
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY18
2,848
FY17
10,408
FY16
9,642
FY15
8,680
EPS (USD)
FY18
1.819
FY17
7.122
FY16
7.016
FY15
4.261
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
25.94
33.15
Price to Sales (TTM)
vs sector
1.76
8.04
Price to Book (MRQ)
vs sector
2.73
4.28
Price to Cash Flow (TTM)
vs sector
14.71
22.37
Total Debt to Equity (MRQ)
vs sector
97.04
17.43
LT Debt to Equity (MRQ)
vs sector
91.06
13.25
Return on Investment (TTM)
vs sector
5.48
13.23
Return on Equity (TTM)
vs sector
11.79
15.27

EXECUTIVE LEADERSHIP

David King
Chairman of the Board, President, Chief Executive Officer, Since 2009
Salary: $1,150,000.00
Bonus: $1,960,370.00
Glenn Eisenberg
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $666,474.00
Bonus: $746,219.00
Gary Huff
Chief Executive Officer, LabCorp Diagnostics, Since 2017
Salary: $525,082.00
Bonus: $708,267.00
John Ratliff
Chief Executive Officer - Covance Drug Development, Since
Salary: $659,750.00
Bonus: $648,415.00
Lisa Uthgenannt
Chief Human Resource Officer, Since 2015
Salary: $440,171.00
Bonus: $318,912.00

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

358 S MAIN ST
BURLINGTON   NC   27215-5837

Phone: +1336.2291127

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

SPONSORED STORIES